Malignant Intracranial Neoplasm — Trials

Malignant Intracranial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

637 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (100)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06613841	Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma(GBM)	recruiting	Early Phase 1	15	Abramson Cancer Center at Penn MedicineOTHER	1	Sep 9, 2026	clinicaltrials
NCT06959979	Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma	recruiting	Early Phase 1	60	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER	1